Valion Bio, Inc. (VBIO) Operating cash flow 2021–2025
Valion Bio, Inc. (VBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.0MFY2025 · since FY2021: -$5.6M → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.0M | -22.3% |
| FY2024 | -$5.7M | +32.7% |
| FY2023 | -$8.5M | +4.6% |
| FY2022 | -$8.9M | -58.9% |
| FY2021 | -$5.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VBIO financial trends
VBIO RevenueVBIO Net incomeVBIO Net marginVBIO Gross profitVBIO Gross marginVBIO Operating incomeVBIO Operating marginVBIO Free cash flowVBIO Capital expendituresVBIO Return on equityVBIO Stock buybacksVBIO Dividends paidVBIO Total assetsVBIO Total liabilitiesVBIO Shareholders’ equityVBIO overview →